Both systemic and local HMGB1 evaluation demonstrate that its expression frequently accompanies advanced disease stages and poorer prognosis in most epithelial tumors including lung, colorectal (CRC) and pancreas (Table 1). This evidence concerns the gene HMGB1 and colorectal carcinoma.